View in EDS

Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression.

Saved in:
Bibliographic Details
Title: Two cases of response to pembrolizumab in epidermal growth factor receptor mutated lung adenocarcinoma patients with programmed death-ligand 1 overexpression.
Authors: Uenami T; Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, Osaka, Japan., Ishijima M; Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, Osaka, Japan., Kanazu M; Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, Osaka, Japan., Kurebe H; Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, Osaka, Japan., Edahiro R; Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, Osaka, Japan., Nishida K; Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, Osaka, Japan., Akazawa Y; Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, Osaka, Japan., Yano Y; Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, Osaka, Japan., Yamaguchi T; Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, Osaka, Japan., Mori M; Department of Thoracic Oncology, National Hospital Organization Toneyama National Hospital, Osaka, Japan.
Source: Annals of translational medicine [Ann Transl Med] 2018 Nov; Vol. 6 (22), pp. 444.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101617978 Publication Model: Print Cited Medium: Print ISSN: 2305-5839 (Print) Linking ISSN: 23055839 NLM ISO Abbreviation: Ann Transl Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2305-5839
DOI:10.21037/atm.2018.10.24